Page last updated: 2024-09-05

alagebrium and alt-946

alagebrium has been researched along with alt-946 in 2 studies

Compound Research Comparison

Studies
(alagebrium)
Trials
(alagebrium)
Recent Studies (post-2010)
(alagebrium)
Studies
(alt-946)
Trials
(alt-946)
Recent Studies (post-2010) (alt-946)
831031500

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawakami, M; Kuroki, M1
Allen, TJ; Jandeleit-Dahm, KA; Lassila, M1

Reviews

2 review(s) available for alagebrium and alt-946

ArticleYear
[Aminoguanidine and other AGE inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines

2002
Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies.
    Annals of the New York Academy of Sciences, 2005, Volume: 1043

    Topics: Amides; Animals; Arteriosclerosis; Diabetic Angiopathies; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Hydrazines; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles

2005